Perez-Lopez Faustino R, Martinez-Dominguez Samuel J, Perez-Roncero Gonzalo R, Hernandez Adrian V
a Department of Obstetrics and Gynecology , University of Zaragoza Faculty of Medicine, Hospital Clinico Lozano-Blesa , Zaragoza , Spain.
b Red de Investigacion de Ginecologia, Obstetricia y Reproduccion , Instituto Aragones de Ciencias de la Salud (IACS) , Zaragoza , Spain.
Eur J Contracept Reprod Health Care. 2018 Jun;23(3):207-217. doi: 10.1080/13625187.2018.1469124. Epub 2018 May 24.
Systematic review and meta-analysis to assess the effects of uterine or paracervical lidocaine application on pain control during IUD insertion.
PubMed and five other electronic research databases were searched through 15 November 2017 for RCTs comparing lidocaine treatment vs. a control (placebo or no-intervention) to prevent pain during IUD insertion. Searched terms included 'IUD insertion', 'lidocaine' and 'randomised controlled trial'. RCTs evaluating lidocaine treatment before IUD insertion without restriction of language, age and IUD type. Pain measured by visual pain scales at tenaculum placement, IUD insertion and immediate post-IUD insertion. Results of random effects meta-analyses were reported as mean differences (MDs) of visual pain scale (VPS) scores and their 95% confidence intervals (CIs).
Eleven RCTs (n = 1458 women) reporting paracervical lidocaine block or uterine mucosa lidocaine application before IUD insertion. Lidocaine produced lower VPS scores during tenaculum placement (MD -0.99, 95% CI: -1.73 to -0.26), IUD insertion (MD -1.26, 95% CI: -2.23 to -0.29) and immediate post-IUD insertion period (MD -1.25, 95% CI: -2.17 to -0.33).
Lidocaine treatment was associated with modest reduction of pain during tenaculum placement and after IUD insertion.
进行系统评价和荟萃分析,以评估子宫或宫颈旁注射利多卡因对宫内节育器(IUD)置入过程中疼痛控制的效果。
检索截至2017年11月15日的PubMed及其他五个电子研究数据库,查找比较利多卡因治疗与对照(安慰剂或无干预)以预防IUD置入过程中疼痛的随机对照试验(RCT)。检索词包括“IUD置入”“利多卡因”和“随机对照试验”。纳入评估IUD置入前利多卡因治疗的RCT,不受语言、年龄和IUD类型限制。在宫颈钳放置、IUD置入时及IUD置入后即刻,通过视觉疼痛量表测量疼痛。随机效应荟萃分析结果以视觉疼痛量表(VPS)评分的平均差值(MDs)及其95%置信区间(CIs)表示。
11项RCT(n = 1458名女性)报告了IUD置入前宫颈旁利多卡因阻滞或子宫黏膜利多卡因注射情况。利多卡因在宫颈钳放置期间(MD -0.99,95% CI:-1.73至-0.26)、IUD置入时(MD -1.26,95% CI:-2.23至-0.29)及IUD置入后即刻(MD -1.25,95% CI:-2.17至-0.33)产生较低的VPS评分。
利多卡因治疗与宫颈钳放置期间及IUD置入后疼痛适度减轻相关。